Unknown NA INTERVENTIONAL 2-arm NCT00725829

Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects

Effects of Simvastatin Versus Simvastatin Combined With Ezetimibe on Blood Coagulation in Patients With Acute Coronary Events: Relationship With Cholesterol-Lowering and Anti-Inflammatory Properties

Sponsor: Jagiellonian University

Conditions Acute Coronary Syndrome

Interventions ezetimibe placebo simvastatin

Updated 7 times since 2017 Last updated: Feb 9, 2009 Started: Jun 30, 2008 Primary completion: Jun 30, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Coronary Syndrome and is currently ongoing. Jagiellonian University leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status NA
Jan 2021 — Jun 2022 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status NA
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jagiellonian University
Merck Sharp & Dohme LLC

Data source: Jagiellonian University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Krakow, Poland